Why do hrt

Overview

Hormone replacement therapy (HRT) refers to medical treatment that supplements hormones, primarily estrogen and progesterone, to alleviate symptoms associated with hormonal decline, most commonly during menopause. The modern era of HRT began in the 1960s with the development of conjugated equine estrogens (Premarin), which became widely prescribed by the 1970s. By the late 1990s, approximately 38% of postmenopausal American women were using HRT, driven by belief in its benefits for heart health and bone protection. The landscape changed dramatically in 2002 when the Women's Health Initiative (WHI) study published findings showing increased risks of breast cancer, heart disease, stroke, and blood clots in women taking combined estrogen-progestin therapy. This led to a 40% decline in HRT prescriptions within one year. Today, HRT remains a treatment option but with more nuanced guidelines emphasizing individualized risk-benefit assessment, typically recommended for women under 60 experiencing moderate-to-severe menopausal symptoms.

How It Works

HRT works by supplementing hormones that naturally decline during menopause, primarily estrogen and progesterone. Estrogen replacement helps regulate body temperature, reducing hot flashes and night sweats that affect approximately 75% of menopausal women. It also maintains vaginal lubrication, prevents bone density loss (reducing fracture risk by 30-50%), and may improve mood and sleep quality. Progesterone is typically added for women with intact uteruses to prevent endometrial hyperplasia and cancer that can result from unopposed estrogen. HRT can be administered through various methods: oral tablets (most common historically), transdermal patches (which bypass liver metabolism and reduce blood clot risk by 80%), gels, creams, or vaginal preparations. Dosing is individualized based on symptoms, age, and risk factors, with current practice favoring the lowest effective dose for the shortest duration needed. Modern formulations often use bioidentical hormones that chemically match those produced by the human body, though their safety profile remains similar to traditional HRT.

Why It Matters

HRT matters because it represents the most effective treatment for moderate-to-severe menopausal symptoms, improving quality of life for millions of women worldwide. Beyond symptom relief, HRT prevents approximately 50-60 hip fractures per 10,000 women per year when used for osteoporosis prevention. The therapy also reduces colorectal cancer risk by approximately 40% according to WHI data. However, the complex risk-benefit profile requires careful consideration: while HRT reduces all-cause mortality in women aged 50-59, it increases stroke risk by 41% and pulmonary embolism by 113% in older women. These competing effects have led to personalized medical approaches where HRT is initiated in recently menopausal women for symptom management rather than long-term disease prevention. The ongoing debate about HRT reflects broader questions about medicalization of aging and how to balance immediate quality-of-life improvements against potential long-term health risks.